相关实验视频
Updated: Jan 26, 2026

T Cells Capture Bacteria by Transinfection from Dendritic Cells
Published on: January 13, 2016
释放2型树突细胞驱动保护性抗瘤CD4+T细胞免疫力
Mikhail Binnewies1, Adriana M Mujal1, Joshua L Pollack2
1Department of Pathology, University of California, San Francisco, San Francisco, CA 94143, USA.
瘤透性骨髓细胞,特别是传统的2型树突细胞 (cDC2),抑制抗瘤CD4+T细胞的反应. 减少调节性T细胞 (Tregs) 逆转了这种情况,增强了CD4+T细胞的活性,并改善了抗瘤保护.
科学领域:
- 免疫学
- 癌症生物学
- 细胞免疫学
背景情况:
- CD4+常规T细胞 (Tconv) 对于抗瘤免疫至关重要,但它们的分化尚不清楚.
- 骨髓细胞,特别是树突细胞,在瘤微环境中的T细胞激活和分化中起着关键作用.
研究的目的:
- 研究骨髓状细胞,特别是常规的2型树突细胞 (cDC2) 在调节抗瘤反应中的CD4+ Tconv分化中的作用.
- 确定调节T细胞 (Tregs) 是否可以增强cDC2介导的CD4+Tconv反应并改善抗瘤免疫力.
主要方法:
- 在小鼠的瘤排泄淋巴结 (tdLNs) 中对髓状细胞的综合性表征.
- 在小鼠瘤模型和人类癌症患者中分析cDC2和T细胞群.
- 在小鼠中评估Treg耗尽对CD4+ Tconv反应和抗瘤保护的影响.
- cDC2和T细胞表型与患者的存活率和抗PD-1治疗反应的相关性.
主要成果:
- 在小鼠 tdLNs 中发现了两个cDC2子集,它们呈现瘤抗原,但未能促进抗瘤CD4+ Tconv分化.
- 在小鼠中,Tregs的消耗增强了cDC2引起强烈的CD4+ Tconv反应和抗瘤保护的能力.
- 在人类患者中发现了类似的cDC2群体,它们相对于Tregs的丰度预测了保护性的CD4+Tconv表型和改善的生存率.
- 在低Treg水平的黑色素瘤患者中,内cDC2密度与丰富的CD4+ Tconv和对抗PD-1治疗的反应相关.
结论:
- 一个涉及cDC2和Tregs的途径抑制了瘤微环境中的有效CD4+Tconv分化.
- 通过调节Treg活性或增强cDC2功能来逆转这种途径可以提高CD4+Tconv的丰度并控制瘤的生长.
- 这些发现突出了通过向cDC2-Treg-Tconv轴来增强癌症免疫疗法的潜在治疗策略.
更多相关视频
08:39An In Vivo Mouse Model to Measure Naïve CD4 T Cell Activation, Proliferation and Th1 Differentiation Induced by Bone Marrow-derived Dendritic Cells
Published on: August 22, 2018
10:04Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
相关概念视频
Neurons: The Cell Body and the Dendrites
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cell-mediated Immune Responses
Cells of the Adaptive Immune Response
What is the Immune System?
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...